BRCA1 variants in a family study of African-American and Latina women

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Genetics

• Publication date

  2005-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00439-004-1240-5PMID 15726418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer genetics in African Americans

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations.

  2002cited by this paper
• On the use of familial aggregation in population-based case probands for calculating penetrance.

  2002cited by this paper
• Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

  2002cited by this paper
• Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites.

  2002cited by this paper
• Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

  2001cited by this paper
• BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study.

  2001cited by this paper
• Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing

  2001cited by this paper
• Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

  2001cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations inBRCA1

  2001cited by this paper
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001cited by this paper
• Mutation analysis of BRCA1 gene in African-American patients with breast cancer.

  2000cited by this paper
• Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families

  2000cited by this paper
• Testing linkage disequilibrium in sibships.

  2000cited by this paper
• A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

  2000cited by this paper
• Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer

  2000cited by this paper
• Insights into the functions of BRCA1 and BRCA2.

  2000cited by this paper
• Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer

  2000cited by this paper
• Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.

  2000cited by this paper
• Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

  2000cited by this paper
• Novel germline BRCA1 mutation (155del4) in an African American with early‐onset breast cancer

  1999cited by this paper
• Evidence for a BRCA1 founder mutation in families of West African ancestry.

  1999cited by this paper
• Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.

  1999cited by this paper
• BRCA1 mutations in African Americans

  1999cited by this paper
• Sequence analysis of the rat Brca1 homolog and its promoter region

  1999cited by this paper
• Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

  1998cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• Consed: a graphical tool for sequence finishing.

  1998cited by this paper
• Base-calling of automated sequencer traces using phred. II. Error probabilities.

  1998cited by this paper
• Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

  1997cited by this paper
• BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

  1997cited by this paper
• Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.

  1997cited by this paper
• Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

  1997cited by this paper
• Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

  1997cited by this paper
• PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.

  1997cited by this paper
• Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

  1996cited by this paper
• Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

  1996cited by this paper
• Inherited breast and ovarian cancer.

  1995cited by this paper
• Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families.

  1988cited by this paper

• Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations

  2023cites this paper
• Investigating Variants of Uncertain Significance: Reclassification Triggers and Drivers in Breast Cancer Predisposition Genes

  2019cites this paper
• Population and breast cancer patients’ analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population

  2019cites this paper
• Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance

  2018cites this paper
• Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers

  2017cites this paper
• Reproductive Endocrinologists’ Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers

  2016cites this paper
• The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective

  2015cites this paper
• BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

  2015cites this paper
• Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis

  2015cites this paper
• Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1

  2014cites this paper
• Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction

  2012cites this paper
• Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review

  2011cites this paper
• Molecular Genetic Characterization of Breast Cancer in Pakistani Population

  2010cites this paper
• BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing

  2010cites this paper
• Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients

  2008cites this paper
• Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women

  2008cites this paper
• Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study

  2008cites this paper
• Differences in Estrogen Receptor Subtype According to Family History of Breast Cancer among Hispanic, but not Non-Hispanic White Women

  2008influential citation
• Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

  2008cites this paper
• Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

  2007influential citation
• Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families

  2007cites this paper
• Racial disparities in blacks with gynecologic cancers

  2007cites this paper
• BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.

  2007cites this paper
• Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

  2007cites this paper
• Prevalence of Pathogenic BRCA 1 Mutation Carriers in 5 US Racial / Ethnic Groups

  2007cites this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cites this paper
• Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.

  2006cites this paper